Adagene (ADAG) Common Equity (2019 - 2025)

Adagene's (ADAG) quarterly Common Equity came in at $35349.5 billion in Q4 2025, down 30.03% year-on-year from $50523.8 billion in Q4 2024, and up 93241469.26% on a QoQ basis from $37.9 million in Q2 2025.

Adagene (ADAG) Common Equity (2019 - 2025) Analysis & Trends

Adagene (ADAG) has 7 years of Common Equity data on file, last reported at $35349.5 billion in Q4 2025.

  • On a quarterly basis, Common Equity fell 30.03% year-over-year to $35349.5 billion in Q4 2025; TTM through Dec 2025 was $35349.5 billion, a 30.03% decrease from a year earlier, with the FY2025 full-year figure at $35349.5 billion, down 30.03% from the prior year.
  • Common Equity for Q4 2025 stood at $35349.5 billion, up from $37.9 million in the prior quarter.
  • Over the last five years, Common Equity for ADAG reached as high as $112684.1 billion in Q2 2022 and fell as low as $37.9 million in Q2 2025.
  • Historically, Common Equity has averaged $43500.1 billion across 5 years, with a median of $42936.7 billion in 2024.
  • Across the five-year window, Common Equity surged 60510309.18% in 2022 and tumbled 100.0% in 2024, its largest moves.
  • Year by year, Common Equity stood at $156.6 million in 2021, then soared by 53072864.39% to $83090.4 billion in 2022, then decreased by 15.08% to $70559.5 billion in 2023, then dropped by 28.4% to $50523.8 billion in 2024, then slumped by 30.03% to $35349.5 billion in 2025.
  • Per Business Quant data, the three most recent Common Equity figures were $35349.5 billion in Q4 2025, $37.9 million in Q2 2025, and $50523.8 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Adagene 198.85 Mn 198.85 Mn - 35,349.55 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 35,349.55 Bn
Jun 30, 2025 37.91 Mn
Dec 31, 2024 50,523.84 Bn
Jun 30, 2024 56.59 Mn
Dec 31, 2023 70,559.50 Bn
Jun 30, 2023 82,793.53 Bn
Dec 31, 2022 83,090.35 Bn
Jun 30, 2022 112,684.12 Bn
Dec 31, 2021 156.56 Mn
Jun 30, 2021 186.22 Mn
Dec 31, 2020 -89.39 Mn
Dec 31, 2019 -57.01 Mn